Jeffrey W Sherman - Net Worth and Insider Trading
Jeffrey W Sherman Net Worth
The estimated net worth of Jeffrey W Sherman is at least $28 Million dollars as of 2024-11-29. Jeffrey W Sherman is the EVP and Chief Medical Officer of Horizon Therapeutics PLC and owns about 236,645 shares of Horizon Therapeutics PLC (HZNP) stock worth over $28 Million. Jeffrey W Sherman is also the Director of Xeris Biopharma Holdings Inc and owns about 113,278 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $390,809. Details can be seen in Jeffrey W Sherman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey W Sherman has not made any transactions after 2023-11-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey W Sherman
Jeffrey W Sherman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey W Sherman owns 4 companies in total, including Horizon Therapeutics PLC (HZNP) , Xeris Biopharma Holdings Inc (XERS) , and Strongbridge Biopharma PLC (SBBP) among others .
Click here to see the complete history of Jeffrey W Sherman’s form 4 insider trades.
Insider Ownership Summary of Jeffrey W Sherman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2023-01-11 | EVP & Chief Medical Officer |
| XERS | Xeris Biopharma Holdings Inc | 2023-11-27 | director |
| SBBP | Strongbridge Biopharma PLC | 2020-05-15 | director |
 | | 2023-10-03 | director |
Jeffrey W Sherman Latest Holdings Summary
Jeffrey W Sherman currently owns a total of 2 stocks. Among these stocks, Jeffrey W Sherman owns 236,645 shares of Horizon Therapeutics PLC (HZNP) as of January 11, 2023, with a value of $28 Million and a weighting of 98.6%. Jeffrey W Sherman also owns 113,278 shares of Xeris Biopharma Holdings Inc (XERS) as of November 27, 2023, with a value of $390,809 and a weighting of 1.4%.
Latest Holdings of Jeffrey W Sherman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2023-01-11 | 236,645 | 116.30 | 27,521,814 |
| XERS | Xeris Biopharma Holdings Inc | 2023-11-27 | 113,278 | 3.45 | 390,809 |
Holding Weightings of Jeffrey W Sherman
Jeffrey W Sherman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey W Sherman has made a total of 8 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 6,736 shares on January 11, 2023, which brought Jeffrey W Sherman around $761,707.
According to the SEC Form 4 filings, Jeffrey W Sherman has made a total of 1 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 5,400 shares on November 27, 2023, which cost Jeffrey W Sherman around $10,098.
Insider Trading History of Jeffrey W Sherman
- 1
Jeffrey W Sherman Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey W Sherman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey W Sherman is 70.11%. GuruFocus also compares Jeffrey W Sherman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey W Sherman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey W Sherman's insider trading performs compared to the benchmark.
Performance of Jeffrey W Sherman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.64 | | | | | |
| Relative Return to S&P 500(%) | 18.56 | | | | | |
Jeffrey W Sherman Ownership Network
Jeffrey W Sherman Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Jeffrey W Sherman is the EVP & Chief Medical Officer of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and Chief Accounting Officer Patrick Mcilvenny .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Jeffrey W Sherman Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey W Sherman. You might contact Jeffrey W Sherman via mailing address: C/o Idm Pharma, Inc., 9 Parker, Suite 100, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
